CIK 0001549595
- Large accelerated filer
Nurix Therapeutics, Inc.
Sign in to watch- Ticker
- NRIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Nov 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270838048
- Phone
- +1 415-660-5320
- Business address
- 1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
- Former names
- Nurix, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,712,859
- in 10 filings, $1.0M under 10b5-1 plans
Net −$1,712,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 50 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-01 | Hansen Gwenn Chief Scientific Officer | Option exercise · Employee Stock Option (right to buy) | −400 | 68,266 | ||
| 2021-10-27 | Ring Christine General Counsel | Option exercise | +800 | $1.86 | $1K | 2,086 |
| 2021-10-27 | Ring Christine General Counsel | Sale | −800 | $35.25 | $28K | 1,286 |
| 2021-10-27 | Ring Christine General Counsel | Option exercise · Employee Stock Option (right to buy) | −800 | 103,666 | ||
| 2021-10-27 | Hansen Gwenn Chief Scientific Officer | Option exercise | +400 | $7.26 | $3K | 14,597 |
| 2021-10-27 | Hansen Gwenn Chief Scientific Officer | Sale | −400 | $35.00 | $14K | 14,197 |
| 2021-10-27 | Hansen Gwenn Chief Scientific Officer | Option exercise · Employee Stock Option (right to buy) | −400 | 68,666 | ||
| 2021-10-11 | Ring Christine General Counsel | Option exercise | +1,200 | $1.86 | $2K | 2,486 |
| 2021-10-11 | Ring Christine General Counsel | Sale | −1,200 | $27.36 | $33K | 1,286 |
| 2021-10-11 | Ring Christine General Counsel | Option exercise · Employee Stock Option (right to buy) | −1,200 | 104,466 | ||
| 2021-10-01 | Hansen Gwenn Chief Scientific Officer | Option exercise | +400 | $7.26 | $3K | 14,597 |
| 2021-10-01 | Hansen Gwenn Chief Scientific Officer | Sale | −400 | $29.92 | $12K | 14,197 |
| 2021-10-01 | Hansen Gwenn Chief Scientific Officer | Option exercise · Employee Stock Option (right to buy) | −400 | 69,066 | ||
| 2021-10-01 | Reinsdorf Judith A Director | Grant or award · Director Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2021-10-01 | Silva Paul M Director | Grant or award · Director Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2021-09-10 | Ring Christine General Counsel | Option exercise | +2,000 | $1.86 | $4K | 3,286 |
| 2021-09-10 | Ring Christine General Counsel | Sale | −700 | $35.10 | $25K | 2,586 |
| 2021-09-10 | Ring Christine General Counsel | Sale | −500 | $35.77 | $18K | 2,086 |
| 2021-09-10 | Ring Christine General Counsel | Sale | −800 | $36.76 | $29K | 1,286 |
| 2021-09-10 | Ring Christine General Counsel | Option exercise · Employee Stock Option (right to buy) | −2,000 | 105,666 |
Page 31 of 32 · 632 trades